Consulting & Innovation
Solutions & Technologies
Infrastructure & Operations
Industries
More
MA_Marcus_Metzner_Corporate
YOUR CONTACT
AdobeStock_103370556_Keyvisual_Stage_Pressemitteilungen

Press Release

19. July 2017

The UK Medicines Verification Organisation is entering into a Letter of Intent with Arvato Systems

Arvato Systems_Gesundheitswesen_Medicine box on the ground with pills on the table

Solution for EU-compliant Drug Protection

  • SecurMed UK engages Arvato Systems to meet its obligations under the Falsified Medicines Directive and associated Delegated Regulation
  • UK Medicines Verification Organisation counts on Arvato Systems for implementation of the major project for the United Kingdom

(Arvato Systems) Gütersloh – Following a robust and competitive selection process Arvato Systems is pleased to announce the entering into a Letter of Intent with SecurMed UK, the UK Medicines Verification Organisation, to implement the IT solution for the United Kingdom.


The UK is one of the largest and most complex markets for medicines supply within Europe and the appointment between SecurMed UK and Arvato Systems represents a significant milestone in the UK’s journey to meet its obligations under the Falsified Medicines Directive and associated Delegated Regulation. Arvato Systems and SecurMed UK  look forward to working together to enable the UK medicines supply and healthcare sectors to successfully implement the UK Medicines Verification System by 9 February 2019.


SecurMed UK is the not-for profit organisation which will manage the UK Medicines Verification System under the supervision of the UK national competent authorities - MHRA and Department of Health. SecurMed UK has been incorporated by the principal supply chain stakeholder associations (Association of British Pharmaceutical Industry (ABPI), British Generic Manufacturers Association (BGMA), British Association of European Pharmaceutical Distributors (BAEPD), Healthcare Distribution Association (HDA), National Pharmacy Association (NPA) and Company Chemists’ Association (CCA)) as required by the Falsified Medicines Directive.


About Arvato Systems

Global IT specialist Arvato Systems supports major companies through digital transformation. More than 3,000 staff in over 25 locations epitomize in-depth technology expertise, industry knowledge and focus on customer requirements.

Arvato Systems was chosen as an official service provider by the European Medicines Verification Organization (EMVO). We rely on a dedicated team of serialization experts that has already carried out numerous international projects.
Working as a team, we develop innovative IT solutions, transition our clients into the Cloud, integrate digital processes and take on IT systems operation and support. As a part of the Bertelsmann-owned Arvato network, we have the unique capability to work across the entire value chain. Our business relationships are personal; we work with our clients as partners, so that together we can achieve long-term success. arvato-systems.com

Your Contact for press inquiries

MA_Marcus_Metzner_Corporate
Marcus Metzner
Chief Marketing Officer